1文献来源 Attar EC, Johnson JL, Amrein PC, et al. Bortezomib added to Daunorubicin and Cytarabine during induction therapy and to intermediate-dose Cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502 [J]. J Clin Oncol, 2013,31(7) :923-929.
展开▼